(QCOM) Qualcomm - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7475251036
Stock: Semiconductors, Licensing, Software, Connectivity, Investments
Total Rating 44
Risk 94
Buy Signal -0.28
| Risk 5d forecast | |
|---|---|
| Volatility | 35.9% |
| Relative Tail Risk | -5.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.25 |
| Alpha | -39.44 |
| Character TTM | |
|---|---|
| Beta | 1.649 |
| Beta Downside | 1.245 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.23% |
| CAGR/Max DD | 0.20 |
EPS (Earnings per Share)
Revenue
Description: QCOM Qualcomm March 04, 2026
Qualcomm (QCOM) develops and commercializes wireless technologies. The company operates in the semiconductor industry, a sector characterized by rapid innovation and high research and development costs.
QCOM has three segments. Qualcomm CDMA Technologies (QCT) supplies integrated circuits and software for mobile, automotive, and IoT applications. This segment aligns with the fabless semiconductor business model, focusing on design and intellectual property rather than manufacturing.
Qualcomm Technology Licensing (QTL) licenses its intellectual property, including patents essential for 3G, 4G, and 5G cellular communication. This licensing model generates significant recurring revenue from a broad base of wireless device manufacturers.
Qualcomm Strategic Initiatives (QSI) invests in early-stage companies across various technology sectors like 5G and AI. This segment also provides services and products to US government agencies.
For more detailed analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- 5G smartphone market growth drives QCT segment revenue
- Automotive chip demand boosts Qualcomms embedded solutions
- Patent licensing revenue faces ongoing legal challenges
- IoT expansion creates new market opportunities for QCT
- Global semiconductor supply chain disruptions impact production costs
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 5.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 1.46 > 1.0 |
| NWC/Revenue: 32.96% < 20% (prev 39.59%; Δ -6.63% < -1%) |
| CFO/TA 0.27 > 3% & CFO 14.39b > Net Income 5.37b |
| Net Debt (7.61b) to EBITDA (13.73b): 0.55 < 3 |
| Current Ratio: 2.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.08b) vs 12m ago -3.83% < -2% |
| Gross Margin: 55.10% > 18% (prev 0.56%; Δ 5454 % > 0.5%) |
| Asset Turnover: 82.62% > 50% (prev 73.23%; Δ 9.40% > 0%) |
| Interest Coverage Ratio: 13.74 > 6 (EBITDA TTM 13.73b / Interest Expense TTM 670.0m) |
Altman Z'' 5.16
| A: 0.28 (Total Current Assets 24.61b - Total Current Liabilities 9.82b) / Total Assets 53.03b |
| B: 0.42 (Retained Earnings 22.50b / Total Assets 53.03b) |
| C: 0.17 (EBIT TTM 9.20b / Avg Total Assets 54.30b) |
| D: 0.77 (Book Value of Equity 23.07b / Total Liabilities 29.96b) |
| Altman-Z'' Score: 5.16 = AAA |
Beneish M -3.07
| DSRI: 1.06 (Receivables 4.15b/3.55b, Revenue 44.87b/40.70b) |
| GMI: 1.02 (GM 55.10% / 55.99%) |
| AQI: 0.98 (AQ_t 0.44 / AQ_t-1 0.45) |
| SGI: 1.10 (Revenue 44.87b / 40.70b) |
| TATA: -0.17 (NI 5.37b - CFO 14.39b) / TA 53.03b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of QCOM shares?
As of March 10, 2026, the stock is trading at USD 138.11 with a total of 12,290,764 shares traded.
Over the past week, the price has changed by -1.44%, over one month by +0.05%, over three months by -21.02% and over the past year by -8.80%.
Over the past week, the price has changed by -1.44%, over one month by +0.05%, over three months by -21.02% and over the past year by -8.80%.
Is QCOM a buy, sell or hold?
Qualcomm has received a consensus analysts rating of 3.73.
Therefor, it is recommend to hold QCOM.
- StrongBuy: 12
- Buy: 5
- Hold: 19
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the QCOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 159.5 | 15.5% |
| Analysts Target Price | 159.5 | 15.5% |
QCOM Fundamental Data Overview March 07, 2026
P/E Trailing = 27.3569
P/E Forward = 12.2399
P/S = 3.2301
P/B = 6.3355
P/EG = 0.5748
Revenue TTM = 44.87b USD
EBIT TTM = 9.20b USD
EBITDA TTM = 13.73b USD
Long Term Debt = 14.82b USD (from longTermDebt, last quarter)
Short Term Debt = 102.0m USD (from shortTermDebt, last fiscal year)
Debt = 14.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.61b USD (from netDebt column, last quarter)
Enterprise Value = 147.92b USD (144.92b + Debt 14.82b - CCE 11.82b)
Interest Coverage Ratio = 13.74 (Ebit TTM 9.20b / Interest Expense TTM 670.0m)
EV/FCF = 11.44x (Enterprise Value 147.92b / FCF TTM 12.93b)
FCF Yield = 8.74% (FCF TTM 12.93b / Enterprise Value 147.92b)
FCF Margin = 28.81% (FCF TTM 12.93b / Revenue TTM 44.87b)
Net Margin = 11.96% (Net Income TTM 5.37b / Revenue TTM 44.87b)
Gross Margin = 55.10% ((Revenue TTM 44.87b - Cost of Revenue TTM 20.14b) / Revenue TTM)
Gross Margin QoQ = 54.55% (prev 55.34%)
Tobins Q-Ratio = 2.79 (Enterprise Value 147.92b / Total Assets 53.03b)
Interest Expense / Debt = 1.14% (Interest Expense 169.0m / Debt 14.82b)
Taxrate = 15.31% (543.0m / 3.55b)
NOPAT = 7.79b (EBIT 9.20b * (1 - 15.31%))
Current Ratio = 2.51 (Total Current Assets 24.61b / Total Current Liabilities 9.82b)
Debt / Equity = 0.64 (Debt 14.82b / totalStockholderEquity, last quarter 23.07b)
Debt / EBITDA = 0.55 (Net Debt 7.61b / EBITDA 13.73b)
Debt / FCF = 0.59 (Net Debt 7.61b / FCF TTM 12.93b)
Total Stockholder Equity = 24.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.88% (Net Income 5.37b / Total Assets 53.03b)
RoE = 21.63% (Net Income TTM 5.37b / Total Stockholder Equity 24.80b)
RoCE = 23.23% (EBIT 9.20b / Capital Employed (Equity 24.80b + L.T.Debt 14.82b))
RoIC = 19.70% (NOPAT 7.79b / Invested Capital 39.56b)
WACC = 10.97% (E(144.92b)/V(159.74b) * Re(11.99%) + D(14.82b)/V(159.74b) * Rd(1.14%) * (1-Tc(0.15)))
Discount Rate = 11.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF] Terminal Value 70.12% ; FCFF base≈12.85b ; Y1≈14.41b ; Y5≈19.19b
[DCF] Fair Price = 187.3 (EV 207.45b - Net Debt 7.61b = Equity 199.84b / Shares 1.07b; r=10.97% [WACC]; 5y FCF grow 14.09% → 2.90% )
EPS Correlation: 26.91 | EPS CAGR: 2.33% | SUE: 0.68 | # QB: 0
Revenue Correlation: 30.53 | Revenue CAGR: 2.51% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.48 | Chg7d=+0.004 | Chg30d=-0.308 | Revisions Net=-20 | Analysts=26
EPS current Year (2026-09-30): EPS=11.19 | Chg7d=+0.011 | Chg30d=-0.825 | Revisions Net=-25 | Growth EPS=-7.0% | Growth Revenue=-1.1%
EPS next Year (2027-09-30): EPS=11.25 | Chg7d=-0.047 | Chg30d=-1.084 | Revisions Net=-25 | Growth EPS=+0.6% | Growth Revenue=+0.9%
[Analyst] Revisions Ratio: -0.91 (1 Up / 21 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.3% (Discount Rate 12.0% - Earnings Yield 3.7%)
[Growth] Growth Spread = -9.0% (Analyst -0.7% - Implied 8.3%)
P/E Forward = 12.2399
P/S = 3.2301
P/B = 6.3355
P/EG = 0.5748
Revenue TTM = 44.87b USD
EBIT TTM = 9.20b USD
EBITDA TTM = 13.73b USD
Long Term Debt = 14.82b USD (from longTermDebt, last quarter)
Short Term Debt = 102.0m USD (from shortTermDebt, last fiscal year)
Debt = 14.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.61b USD (from netDebt column, last quarter)
Enterprise Value = 147.92b USD (144.92b + Debt 14.82b - CCE 11.82b)
Interest Coverage Ratio = 13.74 (Ebit TTM 9.20b / Interest Expense TTM 670.0m)
EV/FCF = 11.44x (Enterprise Value 147.92b / FCF TTM 12.93b)
FCF Yield = 8.74% (FCF TTM 12.93b / Enterprise Value 147.92b)
FCF Margin = 28.81% (FCF TTM 12.93b / Revenue TTM 44.87b)
Net Margin = 11.96% (Net Income TTM 5.37b / Revenue TTM 44.87b)
Gross Margin = 55.10% ((Revenue TTM 44.87b - Cost of Revenue TTM 20.14b) / Revenue TTM)
Gross Margin QoQ = 54.55% (prev 55.34%)
Tobins Q-Ratio = 2.79 (Enterprise Value 147.92b / Total Assets 53.03b)
Interest Expense / Debt = 1.14% (Interest Expense 169.0m / Debt 14.82b)
Taxrate = 15.31% (543.0m / 3.55b)
NOPAT = 7.79b (EBIT 9.20b * (1 - 15.31%))
Current Ratio = 2.51 (Total Current Assets 24.61b / Total Current Liabilities 9.82b)
Debt / Equity = 0.64 (Debt 14.82b / totalStockholderEquity, last quarter 23.07b)
Debt / EBITDA = 0.55 (Net Debt 7.61b / EBITDA 13.73b)
Debt / FCF = 0.59 (Net Debt 7.61b / FCF TTM 12.93b)
Total Stockholder Equity = 24.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.88% (Net Income 5.37b / Total Assets 53.03b)
RoE = 21.63% (Net Income TTM 5.37b / Total Stockholder Equity 24.80b)
RoCE = 23.23% (EBIT 9.20b / Capital Employed (Equity 24.80b + L.T.Debt 14.82b))
RoIC = 19.70% (NOPAT 7.79b / Invested Capital 39.56b)
WACC = 10.97% (E(144.92b)/V(159.74b) * Re(11.99%) + D(14.82b)/V(159.74b) * Rd(1.14%) * (1-Tc(0.15)))
Discount Rate = 11.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF] Terminal Value 70.12% ; FCFF base≈12.85b ; Y1≈14.41b ; Y5≈19.19b
[DCF] Fair Price = 187.3 (EV 207.45b - Net Debt 7.61b = Equity 199.84b / Shares 1.07b; r=10.97% [WACC]; 5y FCF grow 14.09% → 2.90% )
EPS Correlation: 26.91 | EPS CAGR: 2.33% | SUE: 0.68 | # QB: 0
Revenue Correlation: 30.53 | Revenue CAGR: 2.51% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.48 | Chg7d=+0.004 | Chg30d=-0.308 | Revisions Net=-20 | Analysts=26
EPS current Year (2026-09-30): EPS=11.19 | Chg7d=+0.011 | Chg30d=-0.825 | Revisions Net=-25 | Growth EPS=-7.0% | Growth Revenue=-1.1%
EPS next Year (2027-09-30): EPS=11.25 | Chg7d=-0.047 | Chg30d=-1.084 | Revisions Net=-25 | Growth EPS=+0.6% | Growth Revenue=+0.9%
[Analyst] Revisions Ratio: -0.91 (1 Up / 21 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.3% (Discount Rate 12.0% - Earnings Yield 3.7%)
[Growth] Growth Spread = -9.0% (Analyst -0.7% - Implied 8.3%)